Stock 574 PA SHUN INTERNATIONAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pa Shun International Holdings Limited

Equities

574

KYG693781000

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:27 2024-07-12 am EDT 		5-day change 1st Jan Change
0.042 HKD -6.67% Intraday chart for Pa Shun International Holdings Limited -4.55% +35.48%
May. 20 Pa Shun International Holdings Limited Announces Board and Committee Changes CI
May. 16 Pa Shun International In Talks with Hongtai Pharma for Chinese Medicine Collaboration MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 620 141 73.24 80.52 77.99 41.56
Enterprise Value (EV) 1 694.4 222.9 165.9 177.3 184.8 191
P/E ratio -8.59 x -0.71 x -0.18 x -0.24 x -1.8 x 17.7 x
Yield - - - - - -
Capitalization / Revenue 0.76 x 0.17 x 0.15 x 0.94 x 1.09 x 0.32 x
EV / Revenue 0.85 x 0.26 x 0.35 x 2.06 x 2.57 x 1.48 x
EV / EBITDA -147 x 281 x -14.9 x -15 x -56.8 x 146 x
EV / FCF -8.64 x 0.91 x 0.36 x 0.92 x 8.81 x -4.04 x
FCF Yield -11.6% 110% 277% 108% 11.3% -24.8%
Price to Book 0.71 x 0.2 x 0.26 x -1.38 x -0.68 x -0.36 x
Nbr of stocks (in thousands) 1,357,874 1,474,993 1,474,993 1,474,993 1,474,993 1,474,993
Reference price 2 0.4566 0.0956 0.0497 0.0546 0.0529 0.0282
Announcement Date 4/29/19 6/29/20 4/29/21 12/19/23 1/9/24 4/26/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 821.1 845.4 474.8 85.91 71.78 129.4
EBITDA 1 -4.72 0.793 -11.1 -11.85 -3.256 1.312
EBIT 1 -10.17 -4.736 -16.66 -17.13 -5.926 -1.56
Operating Margin -1.24% -0.56% -3.51% -19.94% -8.26% -1.21%
Earnings before Tax (EBT) 1 -48.05 -190.5 -425.8 -323.4 -43.16 3.408
Net income 1 -59.41 -193.7 -418.5 -330.4 -43.38 2.35
Net margin -7.23% -22.91% -88.13% -384.58% -60.43% 1.82%
EPS 2 -0.0532 -0.1338 -0.2837 -0.2240 -0.0294 0.001593
Free Cash Flow 1 -80.35 244.7 460 192.3 20.97 -47.31
FCF margin -9.78% 28.95% 96.88% 223.85% 29.21% -36.55%
FCF Conversion (EBITDA) - 30,863.38% - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/29/19 6/29/20 4/29/21 12/19/23 1/9/24 4/26/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 74.4 81.9 92.7 96.7 107 149
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -15.76 x 103.2 x -8.349 x -8.162 x -32.8 x 113.9 x
Free Cash Flow 1 -80.3 245 460 192 21 -47.3
ROE (net income / shareholders' equity) -7.9% -25.1% -87.2% -301% 49.9% -2.03%
ROA (Net income/ Total Assets) -0.56% -0.29% -1.46% -3.19% -2.44% -0.57%
Assets 1 10,639 67,264 28,722 10,342 1,776 -413
Book Value Per Share 2 0.6400 0.4700 0.1900 -0.0400 -0.0800 -0.0800
Cash Flow per Share 2 0.0400 0.0100 0 0 0 0.0100
Capex 1 15.7 0.09 0.08 0.22 0.03 0.07
Capex / Sales 1.92% 0.01% 0.02% 0.26% 0.04% 0.05%
Announcement Date 4/29/19 6/29/20 4/29/21 12/19/23 1/9/24 4/26/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
PA SHUN INTERNATIONAL HOLDINGS LIMITED Stock Pa Shun International Holdings Limited
+35.48% 7.94M
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-6.59% 22.92B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+14.17% 8.74B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-2.89% 7.94B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-33.14% 6.69B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+22.28% 5.66B
GALENICA AG Stock Galenica AG
+3.99% 4.22B
EBOS GROUP LIMITED Stock EBOS Group Limited
-4.28% 4.02B
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+12.80% 3.41B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+6.92% 3.18B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 574 Stock
  4. Financials Pa Shun International Holdings Limited